Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
1130 Camino Del Mar Suite E, Del Mar, CA, 92014, US
Released By Upperton
Launches hot melt extrusion platform at its Regensburg, Germany facility.
By: Charlie Sternberg
Provides a singular solution to address degradation drivers for pharmaceutical drugs.
Aim to enhance the development and manufacturing of viral vectors and vaccines.
Through this acquisition Merck will add Ohtuvayre to its growing cardio-pulmonary pipeline and portfolio.
Kulkarni will lead the strategic direction and operations of ACG’s engineering division.
The collaboration aims to enable researchers to easily adapt workflows to their applications while improving efficiency and reproducibility.
By: Rachel Klemovitch
Strengthens Ofichem’s integrated development offering, enabling it to offer broader, deeper support from early-phase development through to GMP production.
New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a new Board Member.
Expands its capacity for assembly and packaging for the pharmaceutical sector.
SC 4/2V and SC 4/3V offer dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures.
The company expands its portfolio with Stoboclo and Osenvelt (denosumab-bmwo).
Dr. Barker is an experienced clinical immunologist with broad executive experience across both big pharma and biotech.
Dr. Richard Philipson has 25+ years of industry experience and a successful track record in drug development.
FF-10832’s novel formulation is designed to enhance anti-tumor activity by prolonging plasma half-life and improving targeted delivery to tumors.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
